1. Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons. Issue 1 (January 2016) Authors: Abraham, Hazel Mae A; Wolfson, Leslie; Moscufo, Nicola; Guttmann, Charles R G; Kaplan, Richard F; White, William B Journal: Journal of cerebral blood flow & metabolism Issue: Volume 36:Issue 1(2016) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of azilsartan medoxomil with chlorthalidone in hypertension. (July 2014) Authors: Baker, William L; Nigro, Stefanie C; White, William B Journal: Expert review of cardiovascular therapy Issue: Volume 12:Number 7(2014) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXAMINE: targeting risk and treatment in diabetes – Authors' reply. Issue 10002 (10th October 2015) Authors: White, William B; Kupfer, Stuart; Zannad, Faiez Journal: Lancet Issue: Volume 386:Issue 10002(2015) Page Start: 1445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Issue 9982 (23rd May 2015) Authors: Zannad, Faiez; Cannon, Christopher P; Cushman, William C; Bakris, George L; Menon, Venu; Perez, Alfonso T; Fleck, Penny R; Mehta, Cyrus R; Kupfer, Stuart; Wilson, Craig; Lam, Hung; White, William B Journal: Lancet Issue: Volume 385:Issue 9982(2015) Page Start: 2067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER – Authors' reply. Issue 10247 (1st August 2020) Authors: Agarwal, Rajiv; Rossignol, Patrick; White, William B; Williams, Bryan Journal: Lancet Issue: Volume 396:Issue 10247(2020) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial. Issue 10208 (26th October 2019) Authors: Agarwal, Rajiv; Rossignol, Patrick; Romero, Alain; Garza, Dahlia; Mayo, Martha R; Warren, Suzette; Ma, Jia; White, William B; Williams, Bryan Journal: Lancet Issue: Volume 394:Issue 10208(2019) Page Start: 1540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SO033PATIROMER TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CHRONIC KIDNEY DISEASE (AMBER): PRESPECIFIED RESULTS BY BASELINE SERUM POTASSIUM. (6th June 2020) Authors: Rossignol, Patrick; Arthur, Susan; Conrad, Ansgar; White, William B; Williams, Bryan; Agarwal, Rajiv Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Spironolactone for resistant hypertension in advanced chronic kidney disease—red, amber or green?. Issue 8 (11th February 2020) Authors: Agarwal, Rajiv; Rossignol, Patrick; Williams, Bryan; White, William B Journal: Nephrology dialysis transplantation Issue: Volume 35:Issue 8(2020) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials. (26th August 2022) Authors: Bruce, Ian N; van Vollenhoven, Ronald F; Morand, Eric F; Furie, Richard A; Manzi, Susan; White, William B; Abreu, Gabriel; Tummala, Raj Journal: Rheumatology Issue: Volume 62:Number 4(2023) Page Start: 1526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Thalamic Fractional Anisotropy Predicts Accrual of Cerebral White Matter Damage in Older Subjects with Small-Vessel Disease. Issue 8 (August 2014) Authors: Cavallari, Michele; Moscufo, Nicola; Meier, Dominik; Skudlarski, Pawel; Pearlson, Godfrey D; White, William B; Wolfson, Leslie; Guttmann, Charles RG Journal: Journal of cerebral blood flow & metabolism Issue: Volume 34:Issue 8(2014) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗